← 產業報告目錄

Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-07-22頁數 633報告編號 PH3047

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global pharmaceutical excipients market is projected to reach USD 14.86 billion by 2030 from USD 11.03 billion in 2025, at a CAGR of 6.1% during the forecast period. The expansion of the Pharmaceutical Excipients market has been predominantly driven by the Surging demand for pharmaceutical products and generic medicines, and R&D investments for novel excipient development are predicted to uplift the market in the coming years. Additionally, partnerships and collaboration with pharmaceutical companies and increased emphasis on patient-centric formulations will provide lucrative market growth opportunities. However, regulatory stringency and steep development costs are predicted to restrict the market. The fillers & diluents functionality held the highest share in the pharmaceutical excipients market. The pharmaceutical excipients market, segmented by functionality, includes binders, suspending and viscosity agents, fillers and diluents, flavoring agents and sweeteners, colorants, coating agents, lubricants and glidants, preservatives, disintegrants, emulsifying agents, and other specialized roles. Among these, fillers and diluents play a critical role, especially in the production of solid oral dosage forms like tablets and capsules. Their importance continues to grow with the rising demand for oral medications, which remain the most preferred route due to ease of administration and patient compliance. Fillers and diluents provide bulk to formulations containing small amounts of active pharmaceutical ingredients and help ensure accurate dosage and improved content uniformity. From a manufacturing perspective, they contribute significantly to formulation stability, ease of processing, and scalability in mass production. They simplify processes such as blending, tableting, and encapsulation while enhancing the mechanical strength of tablets. For patients, these excipients improve mouthfeel, taste, and handling, which are crucial factors for pediatric and geriatric populations. As drug formulations become more complex, the demand for high-performance, multifunctional fillers and diluents that support controlled release and bioavailability enhancement is also rising, presenting significant growth opportunities in this excipient category. The oral formulations segment reported the highest share of the formulations segment in 2024. The pharmaceutical excipients market is categorized based on formulation types into oral formulations, topical formulations, parenteral formulations, and other formulations. Among these, the oral formulations segment held the largest market share in 2024, reflecting its dominance as the most widely used and traditional drug delivery method. The convenience, cost-effectiveness, and high patient compliance associated with oral administration make it a preferred choice for patients and healthcare providers. This segment continues to expand due to the rising demand for tablets, capsules, and other solid oral dosage forms. Furthermore, the rapid growth of the biopharmaceutical and generics industries is playing a pivotal role in driving demand for high-quality excipients that enhance drug stability, solubility, and bioavailability in oral products. The increasing prevalence of chronic conditions requiring long-term medication and the trend toward self-administration of drugs also contribute to the growth of this segment. As a result, pharmaceutical companies are investing in innovative oral drug formulations, boosting the need for advanced excipients tailored to these needs. Asia Pacific is expected to grow at the highest CAGR in the global pharmaceutical excipients market from 2025 to 2030. The pharmaceutical excipients market in the Asia Pacific region is expected to grow robustly and register the highest CAGR among all regions during the forecast period. Several interrelated factors are driving this expansion. One of the key advantages is the region’s cost-effective manufacturing capabilities, which make it an attractive hub for pharmaceutical production and outsourcing. Countries like India, China, and South Korea offer abundant raw material availability, skilled labor, and favorable government policies that support pharmaceutical R&D and export-oriented manufacturing. Additionally, the Asia Pacific region has relatively lenient regulatory frameworks compared to Western markets, which accelerates product development and time-to-market. The rapid rise in per capita income, growing awareness of health and wellness, and increased healthcare spending are further fueling demand for generic drugs and, by extension, pharmaceutical excipients. Moreover, a surge in lifestyle-related chronic diseases and expanding geriatric populations have led to greater demand for innovative drug formulations, including oral solids and topical applications. These trends create significant opportunities for local and global excipient manufacturers to expand operations, invest in infrastructure, and form strategic partnerships to meet the growing regional demand. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side-70% and Demand Side-30% • By Designation: Managers-45%, CXOs and Directors-30%, and Executives-25% • By Region: North America-40%, Europe-25%, the Asia Pacific-25%, Latin America-5%, and the Middle East & Africa-5% List of Key Companies Profiled in the Report Key players in the pharmaceutical excipients market include International Flavors & Fragrances Inc. (US), Ashland Inc. (US), Evonik Industries AG (Germany), BASF SE (Germany), Kerry Group plc (Ireland), Roquette Frères (France), MERCK KGaA (Germany), Associated British Foods plc (UK), ADM (US), Wacker Chemie AG (Germany), Air Liquide (France), DOW (US), Berkshire Hathaway Inc. (US), Colorcon (US), DFE PHARMA (Germany), Actylis (US), Croda International Plc(UK), Chemie Trade(India), Gattefossé (France), JRS Pharma(US), and Shin-Etsu Chemical Co., Ltd. (Japan). Research Coverage This research report categorizes the pharmaceutical excipients market by Product [(Organic (Oleochemicals, Carbohydrates, Petrochemicals, Proteins, and Other Organic Chemicals), Inorganic (Calcium Phosphate, Metal Oxides, Halites, Calcium Carbonate, Calcium Sulfate, Other Inorganic Chemicals), Other chemicals], by Functionality (Fillers & Diluents, Suspending & Viscosity Agents, Coating Agents, Binders, Flavoring Agents & Sweeteners, Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, and Other Functionalities), by formulation (Oral (Tablets, Capsules, Liquid Formulations and other oral formulations), Topical Formulations, Parenteral Formulations, and Other Formulations), by Functionality Application (Stabilizers, Taste Making, Modified Release, Solubility & Bioavailability Enhancement and Other Functionality Applications), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical excipients market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the pharmaceutical excipients market. Reasons to Buy this Report The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical excipients market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights on the following pointers: • Analysis of key drivers (Surging demand for generic medications and pharmaceutical formulations, Increased R&D investments to develop novel excipients, A growing focus on patient-centric drug formulations, Strategic collaborations and partnerships with pharmaceutical firms), restraints (Strict and complex regulatory frameworks, High costs associated with excipient development and manufacturing), opportunities (Increasing interest in functional and multifunctional excipients, Technological advancements, particularly in nanotechnology, Expansion into emerging economies across Asia Pacific and Latin America), and Challenges (Ongoing concerns about excipient safety and quality standards, Limited availability and fluctuating costs of key raw materials). • Product Development/Innovation: Detailed insights on upcoming products, research and development activities, and new product approvals/launches in the Pharmaceutical Excipients market. • Market Development: Comprehensive information about lucrative markets; the report analyses the market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical excipients market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the pharmaceutical excipients market.
目錄 Table of Contents
1 INTRODUCTION 61 1.1 STUDY OBJECTIVES 61 1.2 MARKET DEFINITION 61 1.3 STUDY SCOPE 61 1.3.1 MARKET SEGMENTATION 62 1.3.2 REGIONAL SCOPE 63 1.3.3 INCLUSIONS AND EXCLUSIONS 63 1.3.4 YEARS CONSIDERED 64 1.4 CURRENCY CONSIDERED 64 1.5 STAKEHOLDERS 64 1.6 SUMMARY OF CHANGES 65 2 RESEARCH METHODOLOGY 66 2.1 RESEARCH DATA 66 2.1.1 SECONDARY DATA 67 2.1.1.1 Objectives of secondary research 67 2.1.1.2 Key data from secondary sources 68 2.1.2 PRIMARY DATA 68 2.1.2.1 Breakdown of primary interviews 69 2.1.2.2 Key objectives of primary research 69 2.2 MARKET ESTIMATION 70 2.2.1 GLOBAL MARKET ESTIMATION 70 2.2.1.1 Company revenue analysis (Bottom-up approach) 70 2.2.1.2 Revenue share analysis 71 2.2.1.3 MnM repository analysis 72 2.2.1.4 Primary interviews 72 2.2.2 INSIGHTS FROM PRIMARY EXPERTS 73 2.2.3 SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH) 73 2.3 GROWTH RATE PROJECTIONS 75 2.4 DATA TRIANGULATION 77 2.5 RESEARCH ASSUMPTIONS 78 2.6 RESEARCH LIMITATIONS 78 2.7 RISK ANALYSIS 79 3 EXECUTIVE SUMMARY 80   4 PREMIUM INSIGHTS 84 4.1 PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW 84 4.2 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET 85 4.3 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 86 4.4 PHARMACEUTICAL EXCIPIENTS MARKET: EMERGING VS. DEVELOPED MARKETS, 2025 VS. 2030 (USD MILLION) 86 5 MARKET OVERVIEW 87 5.1 INTRODUCTION 87 5.2 MARKET DYNAMICS 87 5.2.1 DRIVERS 88 5.2.1.1 Surging demand for generic medications and pharmaceutical formulations. 88 5.2.1.2 Increased R&D investments to develop novel excipients 90 5.2.1.3 Growing focus on patient-centric drug formulations 91 5.2.1.4 Strategic collaborations and partnerships among pharmaceutical firms 91 5.2.2 RESTRAINTS 92 5.2.2.1 Strict and complex regulatory frameworks 92 5.2.2.2 High cost of excipient development and manufacturing 93 5.2.3 OPPORTUNITIES 94 5.2.3.1 Increasing interest in functional and multifunctional excipients 94 5.2.3.2 Technological advancements in nanotechnology 95 5.2.3.3 Market opportunities in emerging economies 96 5.2.4 CHALLENGES 97 5.2.4.1 Ongoing concerns about excipient safety and quality standards 97 5.2.4.2 Limited availability and fluctuating costs of key raw materials 97 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 98 5.4 PRICING ANALYSIS 99 5.4.1 INDICATIVE PRICING ANALYSIS, BY KEY PLAYER 99 5.4.2 INDICATIVE PRICING ANALYSIS, BY REGION 100 5.5 VALUE CHAIN ANALYSIS 101 5.6 SUPPLY CHAIN ANALYSIS 103 5.7 ECOSYSTEM ANALYSIS 104 5.8 INVESTMENT AND FUNDING SCENARIO 106 5.9 TECHNOLOGY ANALYSIS 107 5.9.1 KEY TECHNOLOGIES 107 5.9.1.1 Co-processed excipient technology 107 5.9.1.2 Nanotechnology-based excipients 107 5.9.2 COMPLEMENTARY TECHNOLOGIES 107 5.9.2.1 3D printing/additive manufacturing 107 5.9.2.2 Process Analytical Technology (PAT) 107 5.9.3 ADJACENT TECHNOLOGIES 107 5.9.3.1 Artificial intelligence in formulation design 107 5.9.3.2 Green chemistry/sustainability tech 107 5.10 PATENT ANALYSIS 108 5.11 TRADE ANALYSIS 109 5.11.1 TRADE DATA FOR HS CODE 290545 110 5.11.1.1 Import data for HS code 290545 110 5.11.1.2 Export data for HS code 290545 111 5.11.2 TRADE DATA FOR HS CODE 350510 112 5.11.2.1 Import data for HS code 350510 112 5.11.2.2 Export data for HS code 350510 113 5.11.3 TRADE DATA FOR HS CODE 290532 114 5.11.3.1 Import data for HS code 290532 114 5.11.3.2 Export data for HS code 290532 115 5.11.4 TRADE DATA FOR HS CODE 283650 116 5.11.4.1 Import data for HS code 283650 116 5.11.4.2 Export data for HS code 283650 117 5.11.5 TRADE DATA FOR HS CODE 250100 118 5.11.5.1 Import data for HS code 250100 118 5.11.5.2 Export data for HS code 250100 119 5.11.6 TRADE DATA FOR HS CODE 290543 120 5.11.6.1 Import data for HS code 290543 120 5.11.6.2 Export data for HS code 290543 121 5.11.7 TRADE DATA FOR HS CODE 3912 122 5.11.7.1 Import data for HS code 3912 122 5.11.7.2 Export data for HS code 3912 123 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 124 5.13 REGULATORY LANDSCAPE 125 5.13.1 REGULATORY FRAMEWORK 125 5.13.1.1 US 125 5.13.1.2 Europe 126 5.13.1.3 China 126 5.13.1.4 India 127 5.13.1.5 Brazil 127 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 128 5.14 PORTER’S FIVE FORCES ANALYSIS 130 5.14.1 BARGAINING POWER OF SUPPLIERS 131 5.14.2 BARGAINING POWER OF BUYERS 131 5.14.3 THREAT OF NEW ENTRANTS 131 5.14.4 THREAT OF SUBSTITUTES 132 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 132 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 132 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 132 5.15.2 KEY BUYING CRITERIA 133 5.16 IMPACT OF AI/GEN AI ON PHARMACEUTICAL EXCIPIENTS MARKET 134 5.16.1 INTRODUCTION 134 5.16.2 MARKET POTENTIAL OF AI ON PHARMACEUTICAL EXCIPIENTS 135 5.16.3 AI USE CASES 135 5.16.4 KEY COMPANIES IMPLEMENTING AI 137 5.16.5 FUTURE OF GENERATIVE AI IN PHARMACEUTICAL EXCIPIENT ECOSYSTEM 137 5.17 IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL EXCIPIENTS MARKET 138 5.17.1 INTRODUCTION 138 5.17.2 KEY TARIFF RATES 138 5.17.3 PRICE IMPACT ANALYSIS 139 5.17.4 IMPACT ON COUNTRY/REGION 140 5.17.4.1 North America 140 5.17.4.1.1 US 140 5.17.4.2 Europe 140 5.17.4.3 Asia Pacific 140 5.17.5 IMPACT ON END-USE INDUSTRIES 140 6 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT 142 6.1 INTRODUCTION 143 6.2 ORGANIC CHEMICALS 143 6.2.1 OLEOCHEMICALS 146 6.2.1.1 Fatty alcohols 149 6.2.1.1.1 Need for improved drug absorption to augment growth 149 6.2.1.2 Mineral stearates 151 6.2.1.2.1 Wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations to drive market 151 6.2.1.3 Glycerin 154 6.2.1.3.1 Non-toxic, colorless, and odorless properties to encourage growth 154 6.2.1.4 Other oleochemicals 156 6.2.2 CARBOHYDRATES 158 6.2.2.1 Sugars 161 6.2.2.1.1 Actual sugars 164 6.2.2.1.1.1 Growing use of actual sugars in pediatric formulations to propel market 164 6.2.2.1.1.2 Lactose 167 6.2.2.1.1.3 Sucrose 169 6.2.2.1.1.4 Dextrose (D-Glucose) 172   6.2.2.1.2 Sugar alcohols 174 6.2.2.1.2.1 Surging trend in consumer demand for healthier alternatives to conventional sweeteners to fuel market 174 6.2.2.1.2.2 Sorbitol 177 6.2.2.1.2.3 Mannitol 179 6.2.2.1.2.4 Other sugar alcohols 182 6.2.2.1.3 Artificial sweeteners 184 6.2.2.1.3.1 Increasing use of sugar substitutes to favor growth 184 6.2.2.2 Cellulose 187 6.2.2.2.1 Microcrystalline cellulose 190 6.2.2.2.1.1 Versatility, safety, and cost-effectiveness to facilitate growth 190 6.2.2.2.2 Cellulose ethers 192 6.2.2.2.2.1 Higher effectiveness than other water-soluble polymers to fuel market 192 6.2.2.2.3 CMC & croscarmellose sodium 195 6.2.2.2.3.1 Growing trend of sourcing CMC from more viable alternatives to boost market 195 6.2.2.2.4 Cellulose esters 198 6.2.2.2.4.1 Increasing focus on targeted and sustained-release drug delivery systems to sustain growth 198 6.2.2.3 Starch 200 6.2.2.3.1 Modified starch 203 6.2.2.3.1.1 Cold-water swelling and gel barrier formation capabilities to fuel market 203 6.2.2.3.2 Dried starch 205 6.2.2.3.2.1 Strong binding and coating properties to augment growth 205 6.2.2.3.3 Converted starch 208 6.2.2.3.3.1 Enhanced solubility and stability for drugs to foster growth 208 6.2.3 PETROCHEMICALS 210 6.2.3.1 Glycols 213 6.2.3.1.1 Polyethylene glycol 216 6.2.3.1.1.1 Solubility, lubricity, and compatibility with APIs to drive market 216 6.2.3.1.2 Propylene glycol 218 6.2.3.1.2.1 Rising use of propylene glycol in oral and injectable formulations to foster growth 218 6.2.3.2 Povidones 220 6.2.3.2.1 Increasing demand for fast-dissolving tablets to spur growth 220 6.2.3.3 Mineral hydrocarbons 223 6.2.3.3.1 Petrolatum 226 6.2.3.3.1.1 Strong presence in topical pharmaceutical formulations to expedite growth 226   6.2.3.3.2 Mineral waxes 228 6.2.3.3.2.1 Utilization of mineral waxes in solid and semi-solid dosage to foster growth 228 6.2.3.3.3 Mineral oils 230 6.2.3.3.3.1 Extensive use of mineral oils as solvents and emollients to propel market 230 6.2.3.4 Acrylic polymers 233 6.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive market 233 6.2.3.5 Other petrochemicals 235 6.2.4 PROTEINS 238 6.2.4.1 Growing applications of proteins as carriers for microparticles and nanoparticles to propel market 238 6.2.5 OTHER ORGANIC CHEMICALS 241 6.3 INORGANIC CHEMICALS 243 6.3.1 CALCIUM PHOSPHATE 246 6.3.1.1 Chemical purity and low incompatibility with drugs to aid growth 246 6.3.2 METAL OXIDES 248 6.3.2.1 Availability of silicon oxides in the hydrophobic, hydrophilic, and granulated forms to aid market growth 248 6.3.3 HALITES 250 6.3.3.1 Increased utilization of halites in vaccines and controlled-release formulations to foster growth 250 6.3.4 CALCIUM CARBONATE 253 6.3.4.1 Short disintegration time and excellent mechanical strength to expedite growth 253 6.3.5 CALCIUM SULFATE 255 6.3.5.1 High quality and cost effectiveness to aid growth 255 6.3.6 OTHER INORGANIC CHEMICALS 257 6.4 OTHER CHEMICALS 260 7 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 263 7.1 INTRODUCTION 264 7.2 FILLERS & DILUENTS 264 7.2.1 IMPROVED COHESION AND DIRECT COMPRESSION TO AMPLIFY GROWTH 264 7.3 SUSPENDING & VISCOSITY AGENTS 267 7.3.1 DRUG STABILITY AND TASTE MASKING ADVANTAGES TO SUSTAIN GROWTH 267 7.4 COATING AGENTS 270 7.4.1 INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO DRIVE MARKET 270 7.5 BINDERS 273 7.5.1 HIGHER FLUIDITY AND COMPRESSIBILITY TO STIMULATE GROWTH 273 7.6 FLAVORING AGENTS & SWEETENERS 276 7.6.1 NEED TO IMPROVE DRUG PALATABILITY TO ADVANCE GROWTH 276   7.7 DISINTEGRANTS 279 7.7.1 NEED FOR RAPID BREAK-UP OF SOLID DOSAGE FORMS TO FOSTER GROWTH 279 7.8 COLORANTS 282 7.8.1 INCREASING USE OF COLORING IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS TO BOOST MARKET 282 7.9 LUBRICANTS & GLIDANTS 285 7.9.1 NON-TOXIC PROPERTIES TO FAVOR GROWTH 285 7.10 PRESERVATIVES 287 7.10.1 GROWING USE OF PRESERVATIVES IN PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY TO DRIVE MARKET 287 7.11 EMULSIFYING AGENTS 290 7.11.1 RISING USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS TO PROMOTE GROWTH 290 7.12 OTHER FUNCTIONALITIES 293 8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 297 8.1 INTRODUCTION 298 8.2 ORAL FORMULATIONS 298 8.2.1 TABLETS 301 8.2.1.1 High palatability and portability to support growth 301 8.2.2 CAPSULES 304 8.2.2.1 Hard-gelatin capsules 307 8.2.2.1.1 Ease of manufacturing and versatility to boost market 307 8.2.2.2 Soft-gelatin capsules 309 8.2.2.2.1 Quick-release properties to contribute to growth 309 8.2.3 LIQUID FORMULATIONS 311 8.2.3.1 Rapid absorption from stomach and intestines to foster growth 311 8.2.4 OTHER ORAL FORMULATIONS 314 8.3 TOPICAL FORMULATIONS 316 8.3.1 GROWING DEMAND FOR TRANSDERMAL PATCHES AND SELF-ADHERING TRANSDERMAL DRUG DELIVERY SYSTEMS TO FUEL MARKET 316 8.4 PARENTERAL FORMULATIONS 319 8.4.1 EMERGENCE OF BIOLOGICAL MOLECULES TO EXPEDITE GROWTH 319 8.5 OTHER FORMULATIONS 323 9 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 326 9.1 INTRODUCTION 327 9.2 STABILIZERS 327 9.2.1 IMPROVED DRUG SHELF LIFE AND LESSER MANUFACTURING DEFECTS TO PROMOTE GROWTH 327 9.3 TASTE MASKING 330 9.3.1 GROWING PREFERENCE FOR BETTER-TASTING SOLID DOSAGE FORMS TO PROPEL MARKET 330   9.4 MODIFIED-RELEASE 333 9.4.1 INCREASING USE OF MODIFIED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO FOSTER GROWTH 333 9.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT 336 9.5.1 INCREASING PREFERENCE FOR SOLUBLE COMPOUNDS TO ACCELERATE GROWTH 336 9.6 OTHER APPLICATIONS 339 10 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION 342 10.1 INTRODUCTION 343 10.2 EUROPE 343 10.2.1 MACROECONOMIC ANALYSIS FOR EUROPE 344 10.2.2 GERMANY 353 10.2.2.1 Booming pharmaceutical manufacturing sector to aid growth 353 10.2.3 UK 360 10.2.3.1 Growing adoption of generics and development of novel excipients to fuel market 360 10.2.4 FRANCE 367 10.2.4.1 Large geriatric population to support growth 367 10.2.5 ITALY 374 10.2.5.1 Budgetary constraints and restricted healthcare spending to impede growth 374 10.2.6 SPAIN 381 10.2.6.1 High consumption of biologics to foster growth 381 10.2.7 REST OF EUROPE 388 10.3 NORTH AMERICA 395 10.3.1 MACROECONOMIC ANALYSIS FOR NORTH AMERICA 395 10.3.2 US 403 10.3.2.1 Well-developed healthcare infrastructure and research bases to aid growth 403 10.3.3 CANADA 410 10.3.3.1 Rising prevalence of cancer to contribute to growth 410 10.4 ASIA PACIFIC 417 10.4.1 MACROECONOMIC ANALYSIS FOR ASIA PACIFIC 417 10.4.2 CHINA 426 10.4.2.1 Emphasis on generics and off-patent drugs to drive market 426 10.4.3 JAPAN 433 10.4.3.1 Rapid growth of elderly population to augment growth 433 10.4.4 INDIA 440 10.4.4.1 High domestic demand for pharmaceuticals and export volume to boost market 440 10.4.5 SOUTH KOREA 447 10.4.5.1 Presence of leading contract research and development organizations to propel market 447 10.4.6 REST OF ASIA PACIFIC 454 10.5 LATIN AMERICA 461 10.5.1 GROWING GERIATRIC POPULATION AND RISING DISEASE PREVALENCE ARE DRIVING MARKET GROWTH 461 10.5.2 MACROECONOMIC ANALYSIS FOR LATIN AMERICA 461 10.5.3 BRAZIL 469 10.5.3.1 Emerging opportunities for excipient manufacturers to drive market 469 10.5.4 MEXICO 476 10.5.4.1 Growing demand for affordable therapies to boost market 476 10.5.5 REST OF LATIN AMERICA 483 10.6 MIDDLE EAST 490 10.6.1 GROWING FOCUS ON UNSATURATED MARKETS TO DRIVE MARKET 490 10.6.2 MACROECONOMIC ANALYSIS FOR MIDDLE EAST 490 10.6.3 GCC COUNTRIES 498 10.6.3.1 Expanding healthcare infrastructure expansion and localization of drug manufacturing to bolster growth 498 10.6.4 REST OF MIDDLE EAST 505 10.7 AFRICA 512 10.7.1 INCREASING PRESENCE OF MAJOR PHARMACEUTICAL COMPANIES TO AUGMENT GROWTH 512 10.7.2 MACROECONOMIC ANALYSIS FOR AFRICA 512 11 COMPETITIVE LANDSCAPE 520 11.1 INTRODUCTION 520 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 520 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET, 2022−2024 520 11.3 REVENUE ANALYSIS, 2020–2024 521 11.4 MARKET SHARE ANALYSIS, 2024 522 11.5 COMPANY VALUATION AND FINANCIAL METRICS 524 11.6 BRAND/PRODUCT COMPARISON 525 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 526 11.7.1 STARS 526 11.7.2 EMERGING LEADERS 526 11.7.3 PERVASIVE PLAYERS 526 11.7.4 PARTICIPANTS 526 11.7.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2024 528 11.7.5.1 Company footprint 528 11.7.5.2 Region footprint 529 11.7.5.3 Product footprint 530 11.7.5.4 Functionality footprint 531 11.7.5.5 Functionality application footprint 532   11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 533 11.8.1 PROGRESSIVE COMPANIES 533 11.8.2 RESPONSIVE COMPANIES 533 11.8.3 DYNAMIC COMPANIES 533 11.8.4 STARTING BLOCKS 533 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 535 11.8.5.1 Detailed list of key startups/SMEs 535 11.8.5.2 Competitive benchmarking of key startups/SMEs 536 11.9 COMPETITIVE SCENARIO 536 11.9.1 PRODUCT LAUNCHES AND APPROVALS 536 11.9.2 DEALS 537 11.9.3 EXPANSIONS 539 12 COMPANY PROFILES 540 12.1 KEY PLAYERS 540 12.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC. 540 12.1.1.1 Business overview 540 12.1.1.2 Products offered 541 12.1.1.3 Recent developments 543 12.1.1.3.1 Deals 543 12.1.1.3.2 Expansions 543 12.1.1.4 MnM view 544 12.1.1.4.1 Key strengths 544 12.1.1.4.2 Strategic choices 544 12.1.1.4.3 Weaknesses and competitive threats 544 12.1.2 ADM 545 12.1.2.1 Business overview 545 12.1.2.2 Products offered 546 12.1.2.3 Recent developments 547 12.1.2.3.1 Deals 547 12.1.2.4 MnM view 547 12.1.2.4.1 Key strengths 547 12.1.2.4.2 Strategic choices 547 12.1.2.4.3 Weaknesses and competitive threats 547 12.1.3 ROQUETTE FRÈRES 548 12.1.3.1 Business overview 548 12.1.3.2 Products offered 549 12.1.3.3 Recent developments 554 12.1.3.3.1 Product launches and approvals 554 12.1.3.4 MnM view 554 12.1.3.4.1 Key strengths 554 12.1.3.4.2 Strategic choices 555 12.1.3.4.3 Weaknesses and competitive threats 555 12.1.4 BASF SE 556 12.1.4.1 Business overview 556 12.1.4.2 Products offered 557 12.1.4.3 Recent developments 560 12.1.4.3.1 Deals 560 12.1.4.3.2 Expansions 560 12.1.4.4 MnM view 560 12.1.4.4.1 Key strengths 560 12.1.4.4.2 Strategic choices 560 12.1.4.4.3 Weaknesses and competitive threats 561 12.1.5 EVONIK 562 12.1.5.1 Business overview 562 12.1.5.2 Products offered 563 12.1.5.3 Recent developments 564 12.1.5.3.1 Expansions 564 12.1.5.4 MnM view 564 12.1.5.4.1 Key strengths 564 12.1.5.4.2 Strategic choices 565 12.1.5.4.3 Weaknesses and competitive threats 565 12.1.6 ASHLAND 566 12.1.6.1 Business overview 566 12.1.6.2 Products offered 567 12.1.6.3 Recent developments 569 12.1.6.3.1 Product launches and approvals 569 12.1.7 KERRY GROUP PLC 571 12.1.7.1 Business overview 571 12.1.7.2 Products offered 572 12.1.7.3 Recent developments 573 12.1.7.3.1 Deals 573 12.1.8 MERCK 574 12.1.8.1 Business overview 574 12.1.8.2 Products offered 575 12.1.8.3 Recent developments 577 12.1.8.3.1 Deals 577 12.1.9 ASSOCIATED BRITISH FOODS PLC 578 12.1.9.1 Business overview 578 12.1.9.2 Products offered 579 12.1.9.3 Recent developments 581 12.1.9.3.1 Deals 581   12.1.10 WACKER CHEMIE AG 582 12.1.10.1 Business overview 582 12.1.10.2 Products offered 583 12.1.11 AIR LIQUIDE 584 12.1.11.1 Business overview 584 12.1.11.2 Products offered 585 12.1.11.3 Recent developments 587 12.1.11.3.1 Product launches and approvals 587 12.1.12 DOW 588 12.1.12.1 Business overview 588 12.1.12.2 Products offered 589 12.1.13 BERKSHIRE HATHAWAY (LUBRIZOL CORPORATION) 590 12.1.13.1 Business overview 590 12.1.13.2 Products offered 591 12.1.13.3 Recent developments 592 12.1.13.3.1 Product launches and approvals 592 12.1.14 COLORCON, INC. 593 12.1.14.1 Business overview 593 12.1.14.2 Products offered 593 12.1.14.3 Recent developments 594 12.1.14.3.1 Product launches and approvals 594 12.1.14.3.2 Deals 594 12.1.14.3.3 Expansions 595 12.1.15 DFE PHARMA 596 12.1.15.1 Business overview 596 12.1.15.2 Products offered 596 12.1.15.3 Recent developments 598 12.1.15.3.1 Deals 598 12.1.16 ACTYLIS 599 12.1.16.1 Business overview 599 12.1.16.2 Products offered 599 12.1.16.3 Recent developments 604 12.1.16.3.1 Deals 604 12.1.17 CRODA INTERNATIONAL PLC 605 12.1.17.1 Business overview 605 12.1.17.2 Products offered 606 12.1.17.3 Recent developments 607 12.1.17.3.1 Deals 607 12.1.17.3.2 Expansions 607 12.1.18 CHEMIE TRADE 608 12.1.18.1 Business overview 608 12.1.18.2 Products offered 608 12.1.19 GATTEFOSSÉ 609 12.1.19.1 Business overview 609 12.1.19.2 Products offered 609 12.1.20 J. RETTENMAIER & SÖHNE GMBH + CO KG 611 12.1.20.1 Business overview 611 12.1.20.2 Products offered 611 12.1.21 SHIN-ETSU CHEMICAL CO., LTD. 613 12.1.21.1 Business overview 613 12.1.21.2 Products offered 614 12.1.21.3 Recent developments 615 12.1.21.3.1 Deals 615 12.1.21.3.2 Expansions 615 12.2 OTHER PLAYERS 616 12.2.1 INNOPHOS 616 12.2.2 MEGGLE GMBH & CO. KG 617 12.2.3 FUJI CHEMICAL INDUSTRIES CO., LTD. 618 12.2.4 COREL PHARMA CHEM 618 12.2.5 BIOGRUND 619 12.2.6 NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD. 620 12.2.7 R.T. VANDERBILT HOLDING COMPANY, INC. 621 12.2.8 BENEO 622 12.2.9 SIAGACHI INDUSTRIES 623 12.2.10 JH NANHANG LIFE SCIENCES CO., LTD. 624 13 APPENDIX 625 13.1 DISCUSSION GUIDE 625 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 629 13.3 CUSTOMIZATION OPTIONS 631 13.4 RELATED REPORTS 631 13.5 AUTHOR DETAILS 632
圖表清單 List of Tables & Figures
TABLE 1 PHARMACEUTICAL EXCIPIENTS MARKET: INCLUSIONS AND EXCLUSIONS 63 TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 76 TABLE 3 PHARMACEUTICAL EXCIPIENTS MARKET: RISK ANALYSIS 79 TABLE 4 PHARMACEUTICAL EXCIPIENTS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 88 TABLE 5 IMPENDING AND ONGOING PATENT EXPIRY OF BLOCKBUSTER THERAPEUTICS, 2023–2035 89 TABLE 6 LIST OF MULTIFUNCTIONAL EXCIPIENTS 94 TABLE 7 INDICATIVE PRICING ANALYSIS OF EXCIPIENT PRODUCTS, BY KEY PLAYER, 2024 99 TABLE 8 INDICATIVE PRICING ANALYSIS OF EXCIPIENT PRODUCTS, BY REGION, 2024 100 TABLE 9 PHARMACEUTICAL EXCIPIENTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 104 TABLE 10 PHARMACEUTICAL EXCIPIENTS MARKET: NUMBER OF PATENTS FILED, 2014–2024 108 TABLE 11 INNOVATIONS AND PATENT REGISTRATIONS, 2022–2023 109 TABLE 12 IMPORT DATA FOR HS CODE 290545 (GLYCEROL), 2020–2024 (USD) 110 TABLE 13 IMPORT DATA FOR HS CODE 290545 (GLYCEROL), 2020–2024 (TONS) 110 TABLE 14 EXPORT DATA FOR HS CODE 290545 (GLYCEROL), 2020–2024 (USD) 111 TABLE 15 EXPORT DATA FOR HS CODE 290545 (GLYCEROL), 2020–2024 (TONS) 111 TABLE 16 IMPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINISED OR ESTERIFIED STARCHES), 2020–2024 (USD) 112 TABLE 17 IMPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINISED OR ESTERIFIED STARCHES), 2020–2024 (TONS) 112 TABLE 18 EXPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINISED OR ESTERIFIED STARCHES), 2020–2024 (USD) 113 TABLE 19 EXPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINISED OR ESTERIFIED STARCHES), 2020–2024 (TONS) 113 TABLE 20 IMPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL "PROPANE-1,2-DIOL), 2020–2024 (USD) 114 TABLE 21 IMPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL "PROPANE-1,2-DIOL), 2020–2024 (TONS) 114 TABLE 22 EXPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL "PROPANE-1,2-DIOL), 2020–2024 (USD) 115 TABLE 23 EXPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL "PROPANE-1,2-DIOL), 2020–2024 (TONS) 115 TABLE 24 IMPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2020–2024 (USD) 116 TABLE 25 IMPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2020–2024 (TONS) 116 TABLE 26 EXPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2020–2024 (USD) 117 TABLE 27 EXPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2020–2024 (TONS) 117 TABLE 28 IMPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2020–2024 (USD) 118 TABLE 29 IMPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2020–2024 (TONS) 118 TABLE 30 EXPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2020–2024 (USD) 119 TABLE 31 EXPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2020–2024 (TONS) 119 TABLE 32 IMPORT DATA FOR HS CODE 290543 (MANNITOL), 2020–2024 (USD) 120 TABLE 33 IMPORT DATA FOR HS CODE 290543 (MANNITOL), 2020–2024 (TONS) 120 TABLE 34 EXPORT DATA FOR HS CODE 290543 (MANNITOL), 2020–2024 (USD) 121 TABLE 35 EXPORT DATA FOR HS CODE 290543 (MANNITOL), 2020–2024 (TONS) 121 TABLE 36 IMPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2020–2024 (USD) 122 TABLE 37 IMPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2020–2024 (TONS) 122 TABLE 38 EXPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2020–2024 (USD) 123 TABLE 39 EXPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2020–2024 (TONS) 123 TABLE 40 PHARMACEUTICAL EXCIPIENTS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 124 TABLE 41 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 128 TABLE 42 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 128 TABLE 43 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 129 TABLE 44 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 129 TABLE 45 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 130 TABLE 46 PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 130 TABLE 47 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%) 133 TABLE 48 KEY BUYING CRITERIA, BY END USER 134 TABLE 49 US ADJUSTED RECIPROCAL TARIFF RATES 138 TABLE 50 COMPARATIVE PRICING ON KEY EXCIPIENT PRE AND POST US 2025 TARIFF 139 TABLE 51 IMPACT ANALYSIS ON END-USE INDUSTRIES 141 TABLE 52 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 143 TABLE 53 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 54 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 55 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 56 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 57 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 58 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 59 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 60 PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 61 PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 62 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 63 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 64 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 65 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 66 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 67 PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 68 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 69 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 70 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 71 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 72 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 73 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 74 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 75 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 76 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 77 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 78 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 79 PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 80 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 81 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 82 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 83 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 84 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 85 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 86 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 87 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 88 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 89 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 90 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 91 PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 92 PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY REGION, 2023–2030 (USD MILLION) 159 TABLE 93 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 94 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 95 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 96 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 97 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 98 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 99 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 100 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 101 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 102 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 103 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 104 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 105 PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 106 PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY REGION, 2023–2030 (USD MILLION) 165 TABLE 107 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 108 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 109 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 110 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 111 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 112 PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 113 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 114 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 115 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 116 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 117 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 118 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 119 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 120 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 121 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 122 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 123 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 124 PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY REGION, 2023–2030 (USD MILLION) 172 TABLE 125 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 126 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 127 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 128 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 129 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY REGION, 2023–2030 (USD MILLION) 174 TABLE 130 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 131 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY REGION, 2023–2030 (USD MILLION) 175 TABLE 132 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 133 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 134 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 135 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 136 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 137 PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 138 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 139 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 140 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 141 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 142 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY REGION, 2023–2030 (USD MILLION) 179 TABLE 143 PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 144 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 145 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 146 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 147 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 148 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY REGION, 2023–2030 (USD MILLION) 181 TABLE 149 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 150 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 151 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 152 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 153 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 154 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY REGION, 2023–2030 (USD MILLION) 184 TABLE 155 PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY REGION, 2023–2030 (USD MILLION) 185 TABLE 156 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 157 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 158 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 159 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 160 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY REGION, 2023–2030 (USD MILLION) 186 TABLE 161 PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 162 PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY REGION, 2023–2030 (USD MILLION) 188 TABLE 163 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 164 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 165 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 166 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 167 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 168 PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY REGION, 2023–2030 (USD MILLION) 190 TABLE 169 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 170 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 171 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 172 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 173 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY REGION, 2023–2030 (USD MILLION) 192 TABLE 174 PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY REGION, 2023–2030 (USD MILLION) 193 TABLE 175 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 176 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 177 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 178 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 179 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY REGION, 2023–2030 (USD MILLION) 195 TABLE 180 PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY REGION, 2023–2030 (USD MILLION) 196 TABLE 181 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 182 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 183 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 184 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 185 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY REGION, 2023–2030 (USD MILLION) 197 TABLE 186 PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY REGION, 2023–2030 (USD MILLION) 198 TABLE 187 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 188 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 189 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 190 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 191 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY REGION, 2023–2030 (USD MILLION) 200 TABLE 192 PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 193 PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY REGION, 2023–2030 (USD MILLION) 201 TABLE 194 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 195 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 196 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 197 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 198 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY REGION, 2023–2030 (USD MILLION) 202 TABLE 199 PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY REGION, 2023–2030 (USD MILLION) 203 TABLE 200 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 201 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 202 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 203 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 204 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY REGION, 2023–2030 (USD MILLION) 205 TABLE 205 PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY REGION, 2023–2030 (USD MILLION) 206 TABLE 206 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 207 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 208 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 209 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 210 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY REGION, 2023–2030 (USD MILLION) 207 TABLE 211 PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY REGION, 2023–2030 (USD MILLION) 208 TABLE 212 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 213 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 214 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 215 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 216 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY REGION, 2023–2030 (USD MILLION) 210 TABLE 217 PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 218 PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY REGION, 2023–2030 (USD MILLION) 211 TABLE 219 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 220 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 221 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 222 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 223 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY REGION, 2023–2030 (USD MILLION) 212 TABLE 224 PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 225 PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY REGION, 2023–2030 (USD MILLION) 214 TABLE 226 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 227 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 228 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 229 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 230 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY REGION, 2023–2030 (USD MILLION) 215 TABLE 231 PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL, BY REGION, 2023–2030 (USD MILLION) 216 TABLE 232 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 233 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 234 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 235 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 236 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL, BY REGION, 2023–2030 (USD MILLION) 218 TABLE 237 PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL, BY REGION, 2023–2030 (USD MILLION) 218 TABLE 238 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 239 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 240 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION) 219 TABLE 241 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 242 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL, BY REGION, 2023–2030 (USD MILLION) 220 TABLE 243 PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY REGION, 2023–2030 (USD MILLION) 221 TABLE 244 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 245 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 246 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 247 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 248 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY REGION, 2023–2030 (USD MILLION) 222 TABLE 249 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 250 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY REGION, 2023–2030 (USD MILLION) 224 TABLE 251 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 252 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 253 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 254 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 255 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY REGION, 2023–2030 (USD MILLION) 225 TABLE 256 PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY REGION, 2023–2030 (USD MILLION) 226 TABLE 257 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 258 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 259 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 260 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 261 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY REGION, 2023–2030 (USD MILLION) 228 TABLE 262 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY REGION, 2023–2030 (USD MILLION) 228 TABLE 263 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 264 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 265 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 266 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 267 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY REGION, 2023–2030 (USD MILLION) 230 TABLE 268 PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY REGION, 2023–2030 (USD MILLION) 231 TABLE 269 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 270 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023–2030 (USD MILLION) 231 TABLE 271 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 272 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 273 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY REGION, 2023–2030 (USD MILLION) 232 TABLE 274 PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY REGION, 2023–2030 (USD MILLION) 233 TABLE 275 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 276 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 277 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 278 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY COUNTRY, 2023–2030 (USD MILLION) 235 TABLE 279 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY REGION, 2023–2030 (USD MILLION) 235 TABLE 280 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS, BY REGION, 2023–2030 (USD MILLION) 236 TABLE 281 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 236 TABLE 282 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 283 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 284 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 285 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS, BY REGION, 2023–2030 (USD MILLION) 238 TABLE 286 PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY REGION, 2023–2030 (USD MILLION) 239 TABLE 287 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 288 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 289 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 290 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 291 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY REGION, 2023–2030 (USD MILLION) 240 TABLE 292 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 241 TABLE 293 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 294 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 295 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 296 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 297 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 243 TABLE 298 PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 299 PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 244 TABLE 300 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 301 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 302 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 303 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 304 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 245 TABLE 305 PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY REGION, 2023–2030 (USD MILLION) 246 TABLE 306 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 307 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 308 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 309 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 310 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY REGION, 2023–2030 (USD MILLION) 248 TABLE 311 PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY REGION, 2023–2030 (USD MILLION) 248 TABLE 312 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 313 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 314 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 315 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 316 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY REGION, 2023–2030 (USD MILLION) 250 TABLE 317 PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY REGION, 2023–2030 (USD MILLION) 251 TABLE 318 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 319 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 320 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 321 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 322 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY REGION, 2023–2030 (USD MILLION) 252 TABLE 323 PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY REGION, 2023–2030 (USD MILLION) 253 TABLE 324 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 325 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 326 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 327 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 328 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY REGION, 2023–2030 (USD MILLION) 255 TABLE 329 PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY REGION, 2023–2030 (USD MILLION) 255 TABLE 330 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 331 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 332 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 333 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY COUNTRY, 2023–2030 (USD MILLION) 257 TABLE 334 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY REGION, 2023–2030 (USD MILLION) 257 TABLE 335 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 258 TABLE 336 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 258 TABLE 337 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 258 TABLE 338 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 339 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 340 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 259 TABLE 341 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 260 TABLE 342 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 260 TABLE 343 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 344 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 345 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 346 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY REGION, 2023–2030 (USD MILLION) 262 TABLE 347 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 264 TABLE 348 PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY REGION, 2023–2030 (USD MILLION) 265 TABLE 349 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023–2030 (USD MILLION) 266 TABLE 350 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023–2030 (USD MILLION) 266 TABLE 351 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023–2030 (USD MILLION) 266 TABLE 352 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2023–2030 (USD MILLION) 267 TABLE 353 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY REGION, 2023–2030 (USD MILLION) 267 TABLE 354 PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY REGION, 2023–2030 (USD MILLION) 268 TABLE 355 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 356 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 357 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 358 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 359 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY REGION, 2023–2030 (USD MILLION) 270 TABLE 360 PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY REGION, 2023–2030 (USD MILLION) 271 TABLE 361 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 362 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 363 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 364 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 273 TABLE 365 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY REGION, 2023–2030 (USD MILLION) 273 TABLE 366 PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION, 2023–2030 (USD MILLION) 274 TABLE 367 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 368 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 369 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 370 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY, 2023–2030 (USD MILLION) 276 TABLE 371 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION, 2023–2030 (USD MILLION) 276 TABLE 372 PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY REGION, 2023–2030 (USD MILLION) 277 TABLE 373 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION) 277 TABLE 374 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 375 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 376 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 377 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY REGION, 2023–2030 (USD MILLION) 279 TABLE 378 PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY REGION, 2023–2030 (USD MILLION) 280 TABLE 379 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023–2030 (USD MILLION) 280 TABLE 380 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023–2030 (USD MILLION) 280 TABLE 381 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023–2030 (USD MILLION) 281 TABLE 382 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2023–2030 (USD MILLION) 281 TABLE 383 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY REGION, 2023–2030 (USD MILLION) 281 TABLE 384 PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY REGION, 2023–2030 (USD MILLION) 283 TABLE 385 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023–2030 (USD MILLION) 283 TABLE 386 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023–2030 (USD MILLION) 283 TABLE 387 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023–2030 (USD MILLION) 284 TABLE 388 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023–2030 (USD MILLION) 284 TABLE 389 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY REGION, 2023–2030 (USD MILLION) 284 TABLE 390 PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY REGION, 2023–2030 (USD MILLION) 285 TABLE 391 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023–2030 (USD MILLION) 286 TABLE 392 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023–2030 (USD MILLION) 286 TABLE 393 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023–2030 (USD MILLION) 286 TABLE 394 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023–2030 (USD MILLION) 287 TABLE 395 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY REGION, 2023–2030 (USD MILLION) 287 TABLE 396 PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY REGION, 2023–2030 (USD MILLION) 288 TABLE 397 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023–2030 (USD MILLION) 288 TABLE 398 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023–2030 (USD MILLION) 289 TABLE 399 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023–2030 (USD MILLION) 289 TABLE 400 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2023–2030 (USD MILLION) 289 TABLE 401 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY REGION, 2023–2030 (USD MILLION) 290 TABLE 402 PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY REGION, 2023–2030 (USD MILLION) 291 TABLE 403 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 291 TABLE 404 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 291 TABLE 405 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 292 TABLE 406 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 292 TABLE 407 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY REGION, 2023–2030 (USD MILLION) 292 TABLE 408 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2023–2030 (USD MILLION) 294 TABLE 409 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023–2030 (USD MILLION) 294 TABLE 410 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023–2030 (USD MILLION) 295 TABLE 411 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023–2030 (USD MILLION) 295 TABLE 412 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023–2030 (USD MILLION) 295 TABLE 413 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2023–2030 (USD MILLION) 296 TABLE 414 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 298 TABLE 415 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 416 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 299 TABLE 417 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 299 TABLE 418 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 300 TABLE 419 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 300 TABLE 420 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 300 TABLE 421 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 301 TABLE 422 TYPICAL COMPOSITION OF TABLETS 301 TABLE 423 PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY REGION, 2023–2030 (USD MILLION) 302 TABLE 424 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023–2030 (USD MILLION) 302 TABLE 425 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023–2030 (USD MILLION) 303 TABLE 426 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023–2030 (USD MILLION) 303 TABLE 427 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023–2030 (USD MILLION) 303 TABLE 428 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY REGION, 2023–2030 (USD MILLION) 304 TABLE 429 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 430 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY REGION, 2023–2030 (USD MILLION) 305 TABLE 431 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 305 TABLE 432 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 305 TABLE 433 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 306 TABLE 434 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 306 TABLE 435 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY REGION, 2023–2030 (USD MILLION) 306 TABLE 436 PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY REGION, 2023–2030 (USD MILLION) 307 TABLE 437 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 307 TABLE 438 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 308 TABLE 439 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 308 TABLE 440 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 308 TABLE 441 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY REGION, 2023–2030 (USD MILLION) 309 TABLE 442 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY REGION, 2023–2030 (USD MILLION) 309 TABLE 443 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 310 TABLE 444 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 310 TABLE 445 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 310 TABLE 446 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION) 311 TABLE 447 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY REGION, 2023–2030 (USD MILLION) 311 TABLE 448 PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 312 TABLE 449 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 312 TABLE 450 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 312 TABLE 451 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 313 TABLE 452 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 313 TABLE 453 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 313 TABLE 454 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 314 TABLE 455 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 315 TABLE 456 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 315 TABLE 457 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 315 TABLE 458 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 316 TABLE 459 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 316 TABLE 460 PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 317 TABLE 461 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 317 TABLE 462 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 318 TABLE 463 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 318 TABLE 464 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 318 TABLE 465 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 319 TABLE 466 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS 319 TABLE 467 EXCIPIENTS USED IN PARENTERAL FORMULATIONS 320 TABLE 468 PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 321 TABLE 469 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 321 TABLE 470 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 321 TABLE 471 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 322 TABLE 472 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 322 TABLE 473 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 322 TABLE 474 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 323 TABLE 475 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 323 TABLE 476 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 324 TABLE 477 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 324 TABLE 478 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 324 TABLE 479 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY REGION, 2023–2030 (USD MILLION) 325 TABLE 480 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 327 TABLE 481 PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2023–2030 (USD MILLION) 328 TABLE 482 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 328 TABLE 483 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 329 TABLE 484 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 329 TABLE 485 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 329 TABLE 486 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2023–2030 (USD MILLION) 330 TABLE 487 PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2023–2030 (USD MILLION) 331 TABLE 488 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023–2030 (USD MILLION) 331 TABLE 489 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023–2030 (USD MILLION) 331 TABLE 490 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023–2030 (USD MILLION) 332 TABLE 491 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2023–2030 (USD MILLION) 332 TABLE 492 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2023–2030 (USD MILLION) 332 TABLE 493 PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY REGION, 2023–2030 (USD MILLION) 334 TABLE 494 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023–2030 (USD MILLION) 334 TABLE 495 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023–2030 (USD MILLION) 334 TABLE 496 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023–2030 (USD MILLION) 335 TABLE 497 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY COUNTRY, 2023–2030 (USD MILLION) 335 TABLE 498 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY REGION, 2023–2030 (USD MILLION) 335 TABLE 499 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY REGION, 2023–2030 (USD MILLION) 337 TABLE 500 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2023–2030 (USD MILLION) 337 TABLE 501 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2023–2030 (USD MILLION) 337 TABLE 502 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2023–2030 (USD MILLION) 338 TABLE 503 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2023–2030 (USD MILLION) 338 TABLE 504 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY REGION, 2023–2030 (USD MILLION) 338 TABLE 505 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 339 TABLE 506 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 340 TABLE 507 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 340 TABLE 508 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 340 TABLE 509 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 341 TABLE 510 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 341 TABLE 511 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 343 TABLE 512 EUROPE: KEY MACROECONOMIC INDICATORS 345 TABLE 513 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 346 TABLE 514 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 346 TABLE 515 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 516 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 517 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 518 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 519 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 520 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 521 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 522 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 523 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 524 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 525 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 526 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 527 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 351 TABLE 528 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 351 TABLE 529 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 530 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 531 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 352 TABLE 532 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 353 TABLE 533 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 534 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 535 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 536 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 537 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 538 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 539 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 540 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 541 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 542 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 543 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 544 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 545 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 358 TABLE 546 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 358 TABLE 547 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 548 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 549 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 359 TABLE 550 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 360 TABLE 551 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 552 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 553 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 554 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 555 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 556 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 557 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 558 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 559 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 560 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 561 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 562 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 563 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 365 TABLE 564 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 365 TABLE 565 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 566 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 567 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 366 TABLE 568 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 367 TABLE 569 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 570 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 571 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 572 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 573 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 574 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 575 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 576 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 577 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 578 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 579 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 580 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 581 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 372 TABLE 582 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 372 TABLE 583 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 584 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 585 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 373 TABLE 586 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 374 TABLE 587 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 588 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 589 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 590 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 591 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 592 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 593 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 594 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 595 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 596 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 597 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 598 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 378 TABLE 599 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 379 TABLE 600 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 379 TABLE 601 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 380 TABLE 602 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 380 TABLE 603 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 380 TABLE 604 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 381 TABLE 605 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 606 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 607 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 608 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 609 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 610 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 611 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 612 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 613 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 614 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 385 TABLE 615 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 385 TABLE 616 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 385 TABLE 617 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 386 TABLE 618 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 386 TABLE 619 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 620 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 621 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 387 TABLE 622 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 388 TABLE 623 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 624 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 625 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 626 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 627 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 628 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 629 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 391 TABLE 630 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 391 TABLE 631 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 391 TABLE 632 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 392 TABLE 633 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 392 TABLE 634 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 392 TABLE 635 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 393 TABLE 636 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 393 TABLE 637 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 638 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 639 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 394 TABLE 640 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 396 TABLE 641 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 396 TABLE 642 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 397 TABLE 643 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 397 TABLE 644 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 397 TABLE 645 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 398 TABLE 646 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 398 TABLE 647 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 398 TABLE 648 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 649 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 650 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 651 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 400 TABLE 652 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 400 TABLE 653 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 400 TABLE 654 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 401 TABLE 655 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 401 TABLE 656 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 402 TABLE 657 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 658 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 659 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 403 TABLE 660 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 404 TABLE 661 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 404 TABLE 662 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 404 TABLE 663 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 664 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 665 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 666 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 406 TABLE 667 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 406 TABLE 668 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 406 TABLE 669 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 670 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 671 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 672 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 408 TABLE 673 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 408 TABLE 674 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 409 TABLE 675 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 676 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 677 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 410 TABLE 678 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 410 TABLE 679 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 680 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 681 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 682 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 683 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 684 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 685 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 686 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 687 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 688 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 414 TABLE 689 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 414 TABLE 690 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 414 TABLE 691 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 415 TABLE 692 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 415 TABLE 693 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 694 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 695 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 416 TABLE 696 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 418 TABLE 697 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 419 TABLE 698 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 419 TABLE 699 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 419 TABLE 700 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 420 TABLE 701 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 420 TABLE 702 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 420 TABLE 703 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 421 TABLE 704 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 421 TABLE 705 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 421 TABLE 706 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 707 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 708 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 709 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 710 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 711 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 424 TABLE 712 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 424 TABLE 713 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 714 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 715 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 425 TABLE 716 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 426 TABLE 717 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 427 TABLE 718 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 427 TABLE 719 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 427 TABLE 720 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 428 TABLE 721 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 428 TABLE 722 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 428 TABLE 723 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 429 TABLE 724 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 429 TABLE 725 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 429 TABLE 726 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 727 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 728 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 729 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 431 TABLE 730 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 431 TABLE 731 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 732 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 733 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 432 TABLE 734 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 433 TABLE 735 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 736 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 737 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 738 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 435 TABLE 739 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 435 TABLE 740 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 435 TABLE 741 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 742 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 743 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 744 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 437 TABLE 745 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 437 TABLE 746 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 437 TABLE 747 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 438 TABLE 748 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 438 TABLE 749 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 750 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 751 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 439 TABLE 752 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 441 TABLE 753 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 441 TABLE 754 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 441 TABLE 755 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 442 TABLE 756 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 442 TABLE 757 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 442 TABLE 758 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 443 TABLE 759 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 443 TABLE 760 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 443 TABLE 761 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 444 TABLE 762 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 444 TABLE 763 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 444 TABLE 764 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 445 TABLE 765 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 445 TABLE 766 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 446 TABLE 767 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 446 TABLE 768 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 446 TABLE 769 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 447 TABLE 770 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 447 TABLE 771 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 448 TABLE 772 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 448 TABLE 773 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 448 TABLE 774 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 449 TABLE 775 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 449 TABLE 776 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 449 TABLE 777 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 450 TABLE 778 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 450 TABLE 779 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 450 TABLE 780 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 451 TABLE 781 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 451 TABLE 782 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 451 TABLE 783 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 452 TABLE 784 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 452 TABLE 785 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 453 TABLE 786 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 453 TABLE 787 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 453 TABLE 788 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 454 TABLE 789 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 455 TABLE 790 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 455 TABLE 791 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 455 TABLE 792 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 456 TABLE 793 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 456 TABLE 794 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 456 TABLE 795 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 457 TABLE 796 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 457 TABLE 797 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 457 TABLE 798 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 458 TABLE 799 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 458 TABLE 800 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 458 TABLE 801 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 459 TABLE 802 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 459 TABLE 803 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 460 TABLE 804 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 460 TABLE 805 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 460 TABLE 806 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 462 TABLE 807 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 462 TABLE 808 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 462 TABLE 809 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 463 TABLE 810 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 463 TABLE 811 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 463 TABLE 812 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 464 TABLE 813 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 464 TABLE 814 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 464 TABLE 815 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 465 TABLE 816 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 465 TABLE 817 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 465 TABLE 818 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 819 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 820 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 821 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 467 TABLE 822 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 467 TABLE 823 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 824 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 825 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 468 TABLE 826 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 469 TABLE 827 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 469 TABLE 828 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 470 TABLE 829 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 470 TABLE 830 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 470 TABLE 831 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 471 TABLE 832 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 471 TABLE 833 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 471 TABLE 834 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 472 TABLE 835 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 472 TABLE 836 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 472 TABLE 837 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 473 TABLE 838 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 473 TABLE 839 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 474 TABLE 840 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 474 TABLE 841 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 475 TABLE 842 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 475 TABLE 843 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 475 TABLE 844 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 476 TABLE 845 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 476 TABLE 846 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 477 TABLE 847 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 477 TABLE 848 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 477 TABLE 849 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 478 TABLE 850 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 478 TABLE 851 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 478 TABLE 852 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 479 TABLE 853 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 479 TABLE 854 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 479 TABLE 855 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 480 TABLE 856 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 480 TABLE 857 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 481 TABLE 858 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 481 TABLE 859 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 482 TABLE 860 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 482 TABLE 861 MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 482 TABLE 862 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 483 TABLE 863 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 483 TABLE 864 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 484 TABLE 865 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION) 484 TABLE 866 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION) 484 TABLE 867 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 485 TABLE 868 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION) 485 TABLE 869 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE, 2023–2030 (USD MILLION) 485 TABLE 870 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION) 486 TABLE 871 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 486 TABLE 872 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION) 486 TABLE 873 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 487 TABLE 874 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION) 487 TABLE 875 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2030 (USD MILLION) 488 TABLE 876 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION) 488 TABLE 877 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION) 489 TABLE 878 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION) 489 TABLE 879 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION) 489 FIGURE 1 PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION 62 FIGURE 2 PHARMACEUTICAL EXCIPIENTS REGIONAL SCOPE 63 FIGURE 3 PHARMACEUTICAL EXCIPIENTS MARKET: YEARS CONSIDERED 64 FIGURE 4 PHARMACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN 66 FIGURE 5 PHARMACEUTICAL EXCIPIENTS MARKET: KEY DATA FROM SECONDARY SOURCES 68 FIGURE 6 PHARMACEUTICAL EXCIPIENTS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 69 FIGURE 7 PHARMACEUTICAL EXCIPIENTS MARKET ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 70 FIGURE 8 COMPANY REVENUE ANALYSIS-BASED ESTIMATION: BOTTOM-UP APPROACH, 2024 71 FIGURE 9 REVENUE SHARE ANALYSIS OF SANDOZ GROUP AG, 2024 71 FIGURE 10 PHARMACEUTICAL EXCIPIENTS MARKET SIZE VALIDATION FROM PRIMARY SOURCES 73 FIGURE 11 PHARMACEUTICAL EXCIPIENTS MARKET: TOP-DOWN APPROACH 74 FIGURE 12 PHARMACEUTICAL EXCIPIENTS MARKET: CAGR PROJECTIONS 75 FIGURE 13 PHARMACEUTICAL EXCIPIENTS MARKET: DATA TRIANGULATION 77 FIGURE 14 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 80 FIGURE 15 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025 VS. 2030 (USD MILLION) 81 FIGURE 16 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025 VS. 2030 (USD MILLION) 82 FIGURE 17 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025 VS. 2030 (USD MILLION) 82 FIGURE 18 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL EXCIPIENTS MARKET 83 FIGURE 19 GROWING DEMAND FOR GENERICS AND PHARMACEUTICAL PRODUCTS TO DRIVE MARKET 84 FIGURE 20 ORGANIC CHEMICALS SEGMENT AND US TO LEAD NORTH AMERICAN MARKET IN 2025 85 FIGURE 21 GERMANY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 86 FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 86 FIGURE 23 PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 87 FIGURE 24 GLOBAL PHARMACEUTICAL R&D SPEND, 2018–2028 90 FIGURE 25 REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL EXCIPIENT PROVIDERS 98 FIGURE 26 INDICATIVE PRICING ANALYSIS EXCIPIENT PRODUCTS, 2024 100 FIGURE 27 INDICATIVE PRICING ANALYSIS OF EXCIPIENT PRODUCTS, BY REGION, 2024 101 FIGURE 28 PHARMACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS 102 FIGURE 29 PHARMACEUTICAL EXCIPIENTS MARKET: SUPPLY CHAIN ANALYSIS 103 FIGURE 30 PHARMACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM ANALYSIS 104 FIGURE 31 PHARMACEUTICAL EXCIPIENTS MARKET: INVESTMENT AND FUNDING SCENARIO, 2022–2024 106 FIGURE 32 PHARMACEUTICAL EXCIPIENTS MARKET: PATENT ANALYSIS, JANUARY 2014–DECEMBER 2024 108 FIGURE 33 PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 131 FIGURE 34 INFLUENCE OF KEY STAKEHOLDERS IN BUYING PROCESS, BY PRODUCT 132 FIGURE 35 KEY BUYING CRITERIA, BY END USER 133 FIGURE 36 PHARMACEUTICAL EXCIPIENTS MARKET: AI USE CASES 135 FIGURE 37 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT 345 FIGURE 38 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT 418 FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 (USD MILLION) 522 FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET, 2024 523 FIGURE 41 EV/EBITDA OF KEY VENDORS 524 FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 525 FIGURE 43 PHARMACEUTICAL EXCIPIENTS MARKET: BRAND/PRODUCT COMPARISON 525 FIGURE 44 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 527 FIGURE 45 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY FOOTPRINT 528 FIGURE 46 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 534 FIGURE 47 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT (2024) 541 FIGURE 48 ADM: COMPANY SNAPSHOT (2024) 546 FIGURE 49 ROQUETTE FRÈRES: COMPANY SNAPSHOT (2024) 549 FIGURE 50 BASF SE: COMPANY SNAPSHOT (2024) 557 FIGURE 51 EVONIK: COMPANY SNAPSHOT (2024) 563 FIGURE 52 ASHLAND: COMPANY SNAPSHOT (2024) 567 FIGURE 53 KERRY GROUP PLC: COMPANY SNAPSHOT (2024) 572 FIGURE 54 MERCK: COMPANY SNAPSHOT (2024) 575 FIGURE 55 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2024) 579 FIGURE 56 WACKER CHEMIE AG: COMPANY SNAPSHOT (2024) 583 FIGURE 57 AIR LIQUIDE: COMPANY SNAPSHOT (2024) 585 FIGURE 58 DOW: COMPANY SNAPSHOT (2024) 589 FIGURE 59 BERKSHIRE HATHAWAY: COMPANY SNAPSHOT (2024) 590 FIGURE 60 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT (2024) 606 FIGURE 61 SHIN-ETSU CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2024) 614

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們